TotalMarketCap

Zura Bio

ZURANasdaq Cayman IslandsHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$362.184 M

$3.76 -6.47%

Close of 6 Nov 2026

As of 6 Nov 2026, Zura Bio (ZURA) has a market capitalization of $362.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$68.7M

Loss-making

Shares outstanding

96,325,411

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #71TevogenTVGN$377.4M
  2. #72C4 TherapeuticsCCCC$362.3M
  3. #73Zura BioZURA$362.2M
  4. #74TRex BioTRXB$355.7M
  5. #75IRulya TherapeuticsIRLA$335.1M

What if Zura Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$293,140.45

Per share 77,963× higher

Bitcoin $1.53T

$15,861.32

Per share 4,218× higher

Apple $5.02T

$52,071.23

Per share 13,849× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Zura Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.